Hyperglycaemia disrupts conducted vasodilation in the resistance vasculature of db/db mice

Vascular Pharmacology

Volumn 103-105, Issue , 2018, Pages 29-35

  Lemmey, Hamish A L ^a   Ye, Xi ^a   Ding, Hong C ^b   Triggle, Christopher R ^b   Garland, Christopher J ^a   Dora, Kim A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

Conducted vasodilation; Db db mice; EDH; Hyperglycaemia; Resistance arteries

Indexed keywords

CALCIUM ION; GLUCOSE; HYPERTONIC SOLUTION; MANNITOL; PROTEINASE ACTIVATED RECEPTOR 2; CALCIUM; OLIGOPEPTIDE; SERYL-LEUCYL-ISOLEUCYL-GLYCYL-ARGINYL-LEUCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENDOTHELIUM CELL; HYPERGLYCEMIA; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASODILATATION; ANIMAL; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BLOOD GLUCOSE; CALCIUM; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLUCOSE; HYPERGLYCEMIA; MANNITOL; MESENTERIC ARTERIES; MICE; OLIGOPEPTIDES; VASODILATION;

EID: 85042267999     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2018.01.002     Document Type: Article

References (47)

1. Ding, H., Hashem, M., Wiehler, W.B., Lau, W., Martin, J., Reid, J., Triggle, C.R., Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse. Br. J. Pharmacol. 146 (2009), 1110–1118, 10.1038/sj.bjp.0706417.
2. Leo, C.H., Hart, J.L., Woodman, O.L., Impairment of both nitric oxide-mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes. Br. J. Pharmacol. 162 (2011), 365–377, 10.1111/j.1476-5381.2010.01023.x.
3. Ma, X., Du, J., Zhang, P., Deng, J., Liu, J., Lam, F., Li, R., Huang, Y., Jin, J., Yao, X., Functional role of TRPV4-KCa2.3 signaling in vascular endothelial cells in normal and streptozotocin-induced diabetic rats. Hypertension 62 (2013), 134–139, 10.1161/HYPERTENSIONAHA.113.01500.
4. Howitt, L., Morris, M.J., Sandow, S.L., Murphy, T.V., Effect of diet-induced obesity on BKCa function in contraction and dilation of rat isolated middle cerebral artery. Vasc. Pharmacol. 61 (2014), 10–15, 10.1016/j.vph.2014.02.002.
5. Chen, H., Kold-Petersen, H., Laher, I., Simonsen, U., Aalkjær, C., Impaired endothelial calcium signaling is responsible for the defective dilation of mesenteric resistance arteries from db/db mice to acetylcholine. Eur. J. Pharmacol. 767 (2015), 17–23, 10.1016/j.ejphar.2015.09.043.
6. Ghosh, S., Lakshmanan, A.P., Hwang, M.J., Kubba, H., Mushannen, A., Triggle, C.R., Ding, H., Metformin improves endothelial function in aortic tissue and microvascular endothelial cells subjected to diabetic hyperglycaemic conditions. Biochem. Pharmacol. 98 (2015), 412–421, 10.1016/j.bcp.2015.10.008.
7. Lagaud, G.J.L., Masih-Khan, E., Kai, S., Van Breemen, C., Dubé G.P., Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries. J. Vasc. Res. 38 (2001), 578–589, 10.1159/000051094.
8. Park, Y., Capobianco, S., Gao, X., Falck, J.R., Dellsperger, K.C., Zhang, C., Role of EDHF in type 2 diabetes-induced endothelial dysfunction. AJP Heart Circ. Physiol. 295 (2008), H1982–H1988, 10.1152/ajpheart.01261.2007.
9. Souza-Smith, F.M., Katz, P.S., Trask, A.J., Stewart, J.A., Lord, K.C., Varner, K.J., Vassallo, D.V., Lucchesi, P.A., Mesenteric resistance arteries in type 2 diabetic db/db mice undergo outward remodeling. PLoS One, 6, 2011, e23337, 10.1371/journal.pone.0023337.
10. Oniki, H., Goto, K., Fujii, K., Kansui, Y., Murakami, N., Ohtsubo, T., Matsumura, K., Kitazono, T., Effects of the superoxide dismutase mimetic tempol on impaired endothelium-dependent and endothelium-independent relaxations in type II diabetic rats. Clin. Exp. Hypertens. 35 (2013), 112–119, 10.3109/10641963.2012.702829.
11. Qiu, S., Mintz, J.D., Salet, C.D., Han, W., Giannis, A., Chen, F., Yu, Y., Su, Y., Fulton, D.J., Stepp, D.W., Increasing muscle mass improves vascular function in obese (db/db) mice. J. Am. Heart Assoc., 3, 2014, e000854, 10.1161/JAHA.114.000854.
12. Wigg, S.J., Tare, M., Tonta, M.A., O'Brien, R.C., Meredith, I.T., Parkington, H.C., Comparison of effects of diabetes mellitus on an EDHF-dependent and an EDHF-independent artery. Am. J. Physiol. Heart Circ. Physiol. 281 (2001), H232–40 http://www.ncbi.nlm.nih.gov/pubmed/11406490.
13. Ding, H., Triggle, C.R., Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium. Vasc. Health Risk Manag. 1 (2005), 55–71, 10.2147/vhrm.1.1.55.58939.
14. + channel-dependent EDHF responses in type II diabetic ZDF rats. Br. J. Pharmacol. 148 (2009), 434–441, 10.1038/sj.bjp.0706748.
15. Absi, M., Oso, H., Khattab, M., The effect of streptozotocin-induced diabetes on the EDHF-type relaxation and cardiac function in rats. J. Adv. Res. 4 (2013), 375–383, 10.1016/j.jare.2012.07.005.
16. Dora, K.A., Gallagher, N.T., McNeish, A., Garland, C.J., Modulation of endothelial cell KCa3.1 channels during endothelium-derived hyperpolarizing factor signaling in mesenteric resistance arteries. Circ. Res. 102 (2008), 1247–1255, 10.1161/CIRCRESAHA.108.172379.
17. + channels in normal and impaired EDHF-dilator responses - relevance to cardiovascular pathologies and drug discovery. Br. J. Pharmacol. 157 (2009), 509–526, 10.1111/j.1476-5381.2009.00132.x.
18. Garland, C.J., Hiley, C.R., Dora, K.A., EDHF: spreading the influence of the endothelium. Br. J. Pharmacol. 164 (2011), 839–852, 10.1111/j.1476-5381.2010.01148.x.
19. Wölfle, S.E., Schmidt, V.J., Hoyer, J., Köhler, R., De Wit, C., Prominent role of KCa3.1 in endothelium-derived hyperpolarizing factor-type dilations and conducted responses in the microcirculation in vivo. Cardiovasc. Res. 82 (2009), 476–483, 10.1093/cvr/cvp060.
20. + in rat skeletal muscle arterioles. Acta Physiol. 219 (2017), 202–218, 10.1111/apha.12656.
21. McGuire, J.J., Hollenberg, M.D., Bennett, B.M., Triggle, C.R., Hyperpolarization of murine small caliber mesenteric arteries by activation of endothelial proteinase-activated receptor 2. Can. J. Physiol. Pharmacol. 82 (2004), 1103–1112, 10.1139/y04-121.
22. Takano, H., Dora, K.A., Spitaler, M.M., Garland, C.J., Spreading dilatation in rat mesenteric arteries associated with calcium-independent endothelial cell hyperpolarization. J. Physiol. 556 (2004), 887–903, 10.1113/jphysiol.2003.060343.
23. Matsumoto, T., Ishida, K., Taguchi, K., Kobayashi, T., Kamata, K., Mechanisms underlying enhanced vasorelaxant response to protease-activated receptor 2-activating peptide in type 2 diabetic Goto-Kakizaki rat mesenteric artery. Peptides 30 (2009), 1729–1734, 10.1016/j.peptides.2009.06.014.
24. +-channel-mediated endothelium-dependent local and conducted dilation of small mesenteric arteries from ApoE −/− mice. Cardiovasc. Res. 92 (2011), 199–208, 10.1093/cvr/cvr181.
25. Waldron, G.J., Ding, H., Lovren, F., Kubes, P., Triggle, C.R., Acetylcholine-induced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase. Br. J. Pharmacol. 128 (1999), 653–658, 10.1038/sj.bjp.0702858.
26. Ding, H., Kubes, P., Triggle, C.R., Potassium- and acetylcholine-induced vasorelaxation in mice lacking endothelial nitric oxide synthase. Br. J. Pharmacol. 129 (2000), 1194–1200, 10.1038/sj.bjp.0703144.
27. Pannirselvam, M., Verma, S., Anderson, T.J., Triggle, C.R., Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db −/−) mice: role of decreased tetrahydrobiopterin bioavailability. Br. J. Pharmacol. 136 (2002), 255–263, 10.1038/sj.bjp.0704683.
28. Pannirselvam, M., Ding, H., Anderson, T.J., Triggle, C.R., Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice. Eur. J. Pharmacol. 551 (2006), 98–107, 10.1016/j.ejphar.2006.08.086.
29. 2 + events, and IKCa channels, reducing arteriolar tone. Proc. Natl. Acad. Sci. 109 (2012), 18174–18179, 10.1073/pnas.1211946109.
30. Winter, P., Dora, K.A., Spreading dilatation to luminal perfusion of ATP and UTP in rat isolated small mesenteric arteries. J. Physiol. 582 (2007), 335–347, 10.1113/jphysiol.2007.135202.
31. + channels modulate conducted dilation in rat isolated small mesenteric arteries. Microcirculation 18 (2011), 487–500, 10.1111/j.1549-8719.2011.00109.x.
32. Akamine, E.H., Kawamoto, E.M., Scavone, C., Nigro, D., Carvalho, M.H.C., Tostes, R.D.C.A., Britto, L.R.G., Fortes, Z.B., Correction of endothelial dysfunction in diabetic female rats by tetrahydrobiopterin and chronic insulin. J. Vasc. Res. 43 (2006), 309–320, 10.1159/000093196.
33. Wever, R.M.F., van Dam, T., van Rijn, H.J.M., de Groot, F., Rabelink, T.J., Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem. Biophys. Res. Commun. 237 (1997), 340–344, 10.1006/bbrc.1997.7069.
34. Pannirselvam, M., Wiehler, W.B., Anderson, T., Triggle, C.R., Enhanced vascular reactivity of small mesenteric arteries from diabetic mice is associated with enhanced oxidative stress and cyclooxygenase products. Br. J. Pharmacol. 144 (2005), 953–960, 10.1038/sj.bjp.0706121.
35. 2 increases production of constrictor prostaglandins in smooth muscle leading to enhanced arteriolar tone in type 2 diabetic mice. Am. J. Physiol. Heart Circ. Physiol. 292 (2007), H649–56, 10.1152/ajpheart.00596.2006.
36. Wang, R., Liu, Y., Sauvé R., Anand-Srivastava, M.B., Hyperosmolality-induced abnormal patterns of calcium mobilization in smooth muscle cells from non-diabetic and diabetic rats. Mol. Cell. Biochem. 183 (1998), 79–85, 10.1023/A:1006813223216.
37. Williams, S.B., Goldfine, A.B., Timimi, F.K., Ting, H.H., Roddy, M.A., Simonson, D.C., Creager, M.A., Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97 (1998), 1695–1701, 10.1161/01.CIR.97.17.1695.
38. Sercombe, R., Vicaut, E., Oudart, N., Sercombe, C., Girard, P., Acetylcholine-induced relaxation of rabbit basilar artery in vitro is rapidly reduced by reactive oxygen species in acute hyperglycemia: role of NADPH oxidase. J. Cardiovasc. Pharmacol. 44 (2004), 507–516, 10.1097/01.fjc.0000141477.59748.84.
39. Kuroki, T., Inoguchi, T., Umeda, F., Ueda, F., Nawata, H., High glucose induces alteration of gap junction permeability and phosphorylation of connexin-43 in cultured aortic smooth muscle cells. Diabetes 47 (1998), 931–936, 10.2337/diabetes.47.6.931.
40. Wölfle, S.E., De Wit, C., Intact endothelium-dependent dilation and conducted responses in resistance vessels of hypercholesterolemic mice in vivo. J. Vasc. Res. 42 (2005), 475–482, 10.1159/000088101.
41. + channel activation. Arterioscler. Thromb. Vasc. Biol. 33 (2013), 1892–1901, 10.1161/ATVBAHA.113.301514.
42. Rai, A., Riemann, M., Gustafsson, F., Holsteln-Rathlou, N.H., Torp-Pedersen, C., Streptozotocin-induced diabetes decreases conducted vasoconstrictor response in mouse cremaster arterioles. Horm. Metab. Res. 40 (2008), 651–654, 10.1055/s-0028-1083813.
43. Sato, T., Haimovici, R., Kao, R., Li, A.F., Roy, S., Downregulation of connexin 43 expression by high glucose reduces gap junction activity in microvascular endothelial cells. Diabetes 51 (2002), 1565–1571, 10.2337/diabetes.51.5.1565.
44. Sandow, S.L., Neylon, C.B., Chen, M.X., Garland, C.J., Spatial separation of endothelial small- and intermediate-conductance calcium-activated potassium channels (KCa) and connexins: possible relationship to vasodilator function?. J. Anat. 209 (2006), 689–698, 10.1111/j.1469-7580.2006.00647.x.
45. De Wit, C., Griffith, T.M., Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses. Pflugers Arch. Eur. J. Physiol. 459 (2010), 897–914, 10.1007/s00424-010-0830-4.
46. Looft-Wilson, R.C., Billaud, M., Johnstone, S.R., Straub, A.C., Isakson, B.E., Interaction between nitric oxide signaling and gap junctions: effects on vascular function. Biochim. Biophys. Acta Biomembr. 1818 (2012), 1895–1902, 10.1016/j.bbamem.2011.07.031.
47. Beckman, J.A., Goldfine, A.B., Gordon, M.B., Garrett, L.A., Creager, M.A., Inhibition of protein kinase Cβ prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ. Res. 90 (2002), 107–111, 10.1161/hh0102.102359.